TY - JOUR
T1 - CT-derived Chest Muscle Metrics for Outcome Prediction in Patients with COVID-19
AU - Schiaffino, Simone
AU - Albano, Domenico
AU - Cozzi, Andrea
AU - Messina, Carmelo
AU - Arioli, Roberto
AU - Bnà, Claudio
AU - Bruno, Antonio
AU - Carbonaro, Luca A
AU - CARRIERO, Alessandro
AU - Carriero, Serena
AU - Danna, Pietro S C
AU - D'Ascoli, Elisa
AU - De Berardinis, Claudia
AU - Della Pepa, Gianmarco
AU - Falaschi, Zeno
AU - Gitto, Salvatore
AU - Malavazos, Alexis E
AU - Mauri, Giovanni
AU - Monfardini, Lorenzo
AU - Paschè, Alessio
AU - Rizzati, Roberto
AU - Secchi, Francesco
AU - Vanzulli, Angelo
AU - Tombini, Valeria
AU - Vicentin, Ilaria
AU - Zagaria, Domenico
AU - Sardanelli, Francesco
AU - Sconfienza, Luca M
N1 - Publisher Copyright:
© RSNA, 2021
PY - 2021
Y1 - 2021
N2 - Background Lower muscle mass is a known predictor of unfavorable outcome, but its prognostic impact on COVID-19 patients is unknown. Purpose To investigate the contribution of CT-derived muscle status in predicting clinical outcomes in COVID-19 patients. Materials and Methods Clinical/laboratory data and outcomes (intensive care unit [ICU] admission and death) were retrospectively retrieved for patients with reverse transcriptase polymerase chain reaction-confirmed COVID-19, who underwent chest CT on admission in four hospitals in Northern Italy from February 21 to April 30, 2020. Extent and type of pulmonary involvement, mediastinal lymphadenopathy, and pleural effusion were assessed. Cross-sectional areas and attenuation of paravertebral muscles were measured on axial CT images at T5 and T12 vertebral level. Multivariable linear and binary logistic regression, including calculation odds ratios (OR) with 95% confidence intervals (CIs), were used to build four models to predict ICU admission and death, tested and compared using receiver operating characteristic curve (ROC) analysis. Results A total 552 patients (364 men; median age 65 years, interquartile range 54-75) were included. In a CT-based model, lower-than-median T5 paravertebral muscle area showed the highest ORs for ICU admission (OR 4.8, 95% CI 2.7-8.5; P<.001) and death (OR 2.3, 95% CI 1.0-2.9; P=.027). When clinical variables were included in the model, lower-than-median T5 paravertebral muscle area still showed the highest ORs both for ICU admission (OR 4.3; 95% CI 2.5-7.7; P<.001) and death (OR 2.3, 95% CI 1.3-3.7; P=.001). At ROC analysis, the CT-based model and the model including clinical variables showed the same area under the curve (AUC) for ICU admission prediction (AUC 0.83, P=.380) and were not different in predicting death (AUC 0.86 versus AUC 0.87, respectively, P=.282). Conclusion In hospitalized patients with COVID-19, lower muscle mass on CT was independently associated with ICU admission and hospital mortality.
AB - Background Lower muscle mass is a known predictor of unfavorable outcome, but its prognostic impact on COVID-19 patients is unknown. Purpose To investigate the contribution of CT-derived muscle status in predicting clinical outcomes in COVID-19 patients. Materials and Methods Clinical/laboratory data and outcomes (intensive care unit [ICU] admission and death) were retrospectively retrieved for patients with reverse transcriptase polymerase chain reaction-confirmed COVID-19, who underwent chest CT on admission in four hospitals in Northern Italy from February 21 to April 30, 2020. Extent and type of pulmonary involvement, mediastinal lymphadenopathy, and pleural effusion were assessed. Cross-sectional areas and attenuation of paravertebral muscles were measured on axial CT images at T5 and T12 vertebral level. Multivariable linear and binary logistic regression, including calculation odds ratios (OR) with 95% confidence intervals (CIs), were used to build four models to predict ICU admission and death, tested and compared using receiver operating characteristic curve (ROC) analysis. Results A total 552 patients (364 men; median age 65 years, interquartile range 54-75) were included. In a CT-based model, lower-than-median T5 paravertebral muscle area showed the highest ORs for ICU admission (OR 4.8, 95% CI 2.7-8.5; P<.001) and death (OR 2.3, 95% CI 1.0-2.9; P=.027). When clinical variables were included in the model, lower-than-median T5 paravertebral muscle area still showed the highest ORs both for ICU admission (OR 4.3; 95% CI 2.5-7.7; P<.001) and death (OR 2.3, 95% CI 1.3-3.7; P=.001). At ROC analysis, the CT-based model and the model including clinical variables showed the same area under the curve (AUC) for ICU admission prediction (AUC 0.83, P=.380) and were not different in predicting death (AUC 0.86 versus AUC 0.87, respectively, P=.282). Conclusion In hospitalized patients with COVID-19, lower muscle mass on CT was independently associated with ICU admission and hospital mortality.
UR - https://iris.uniupo.it/handle/11579/122568
U2 - 10.1148/radiol.2021204141
DO - 10.1148/radiol.2021204141
M3 - Article
SN - 0033-8419
JO - Radiology
JF - Radiology
ER -